Funding

 

SECTION I: ESTIMATION OF COSTS

1 Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
 

28 800€

 

…in terms of product development
 

25 600€

 

…in terms of mass production
 

30 400€

 

… in terms of marketing
 

3 000€

 

 

2 Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs
Year 1 Year 2 Year 3 Year 4 Year 5
Fixed costs 15 360€ 30 720€ 48 640€ 72 960€ 92 160€
Personnel 15 360€ 30 720€ 48 640€ 72 960€ 92 160€
Other running costs 4 800€ 9 600€ 15 200€ 22 800€ 14 400€
Marketing costs 4 800€ 9 600€ 15 200€ 22 800€ 43 200€
TOTAL EXPECTED COSTS 40 320€ 80 640€ 127 680€ 189 520€ 241 920€
Price per Unit 1500€ 1500€ 1400€ 1400€ 1300€
Type of Unit system
Number of Units 30 60 100 150 200
TOTAL Expected Revenues 45 000€ 90 000€ 140 000€ 210 000€ 260 000€
CASH FLOW REQUIRED (REVENUES-COSTS) 4 680€ 9 360€ 12 320€ 20 480€ 18 080€
TOTAL CAPITAL required for five years 680 080€= 40 320€+80 640€+127 680€+189 520€+241 920€

 

SECTION 2: QUALITATIVE FACTORS

4 Dimension of identified target groups
Detailed comment 

European funding – 80%

National funding  – 20%

 

6 Evaluation of financial Risks for R&D result
There are enough scientific investigations on Electro Sleeping therapy, enough positive results of testing of Electro Sleeping System    in real conditions in hospitals and therefore in fact there are not any risks for the  R&D result. 

 

 

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 

1. European Funding 

Define relevance of the product with the following potential funding sources and comment

Note: INTERVALUE partners are expected to pre-define a list of existing European funding sources for product development available for the country and advisors will check whether the proposed product is relevant for that funding source or may define an additional source
1.  

2.

2 National Funding
Note: INTERVALUE partners are expected to pre-define a list of existing national funding sources for product development available for the country and advisors will check whether the proposed product is relevant for that funding source or may define an additional source
1.  

2.


3 Private funding
Note: INTERVALUE partners are expected to pre-define a list of existing private funding sources for product development available for the country and advisors will check whether the proposed product is relevant for that funding source or may define an additional source
1.  

2.

4 Other

 

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
 

The most suitable funding opportunities for exploitation of R&D results is European funding.

 

 

Decision of evaluation (Please tick  as appropriate)

The R&D has a high potential of exploitation                                  Yes
The R&D result needs minor revisions                                               Yes
The R&D result needs moderate revisions                                         No
The R&D result needs major revisions                                                No
The R&D result has no potential of exploitation

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project